Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)
HKSE · HKD · Healthcare · Medical Distribution
HK$11.20 (-0.36%) as of
Key statistics
- Market cap
- 41.53B
- P/E (TTM)
- 7.78
- Forward P/E
- 5.90
- EPS (TTM)
- 1.440
- Dividend yield
- 4.64%
- 52-week range
- 10.700 – 12.410
- Beta
- 0.15
- Revenue (TTM)
- 289.46B
- Profit margin
- 1.65%
- Analyst target
- HK$13.90
- Volume
- 3.66M
About Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Shanghai, China
- Employees
- 48,640
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.